Definitive Healthcare Q1 revenue $55.9M (-6% YoY); net loss $192.4M on $197M goodwill impairment

Definitive Healthcare Corp.

2026-Q1 EPS reported -$1.32 revenue$55,929,000

Revenue of $55.9M, at top end of guidance, down 6% from $59.2M in Q1 2025.
Net loss of $(192.4)M includes $197.2M goodwill impairment; adjusted net income rose to $8.5M from $7.0M.
Adjusted EBITDA $15.3M (27% margin) vs $14.7M (25%) YoY; operating cash flow $11.6M, unlevered FCF $18.0M.
Q2 2026 guidance: revenue $55-56M, adj. EBITDA $13.5-14.5M. Full-year: revenue $220-226M, adj. EBITDA $55-59M.
Customer wins include a six-figure multi-year life sciences deal and Monocl expansion from a biopharma acquisition.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Definitive Healthcare Corp. reported Q1 2026 results: revenue $55.9 million, net income $(192.4) million.

Period: Q1 2026
Revenue: $55.9 million
Net income: $(192.4) million
Result: reported results

Exact text from the filing

First Quarter 2026 Financial Highlights: • Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. • Net Loss , inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0001193125-26-211946

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.